Literature DB >> 26199115

Genetic and Non-Genetic Determinants of Circulating Levels of Adiponectin in a Cohort of Chilean Subjects.

Fernando Lanas1, Pamela Serón, Nicolás Saavedra, Jenny Ruedlinger, Luis Salazar.   

Abstract

BACKGROUND: Low adiponectin levels have been associated with obesity, diabetes, coronary disease and polymorphisms. The aim of this study was to assess the clinical and genetic factors related to adiponectin levels in a Chilean adult population.
METHODS: Four groups of 27 individuals, stratified by gender and abdominal obesity, were included in this cross-sectional study. Physical activity level, cardiovascular risk factors and therapy were assessed. Anthropometric measurements, adiponectin, glucose, insulin, hs-CRP, rs1501299, rs2241766, rs266729 and rs17300539 single nucleotide polymorphisms of the adiponectin gene were determined.
RESULTS: Adiponectin levels were inversely correlated with waist circumference, waist-to-hip ratio, weight, body mass index, insulin levels, homeostasis model insulin resistance index (HOMA-IR) and physical activity. Mean adiponectin levels were lower in men (10.1 ± 3.6 vs 11.9 ± 2.9 μg/mL, p = 0.0051), obese (9.9 ± 3.2 vs 12.1 ± 3.3, p < 0.01), physically inactive (8.9 ± 3.2 vs 11.0 ± 2.8, p = 0.015) and insulin-resistant individuals (10.2 ± 3.1 vs 12.9 ± 3.9; p = 0.005). Adiponectin levels were lower in subjects with GG genotype (rs1501299) compared with those with TT or GT variants (6.9 ± 4.6 vs 12.2 ± 2.9 and 11.5 ± 3.4 μg/mL, p = 0.006) but were similar in the other polymorphisms studied.
CONCLUSION: Lower adiponectin levels were related to gender, abdominal obesity, physical activity and insulin resistance and were less influenced by the polymorphisms studied.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26199115     DOI: 10.1007/s40291-015-0146-3

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  37 in total

Review 1.  Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease.

Authors:  Claudia Menzaghi; Vincenzo Trischitta; Alessandro Doria
Journal:  Diabetes       Date:  2007-02-15       Impact factor: 9.461

2.  Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones.

Authors:  G A Laughlin; E Barrett-Connor; S May
Journal:  Int J Obes (Lond)       Date:  2006-07-04       Impact factor: 5.095

3.  Association of adiponectin gene -11377C>G polymorphism with adiponectin levels and the metabolic syndrome in Thais.

Authors:  Kanjana Suriyaprom; Benjaluck Phonrat; Rungsunn Tungtrongchitr
Journal:  Asia Pac J Clin Nutr       Date:  2014       Impact factor: 1.662

4.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

5.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

6.  ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study.

Authors:  Daruneewan Warodomwichit; Jian Shen; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; James M Peacock; James E Hixson; Robert J Straka; Michael A Province; Ping An; Chao-Qiang Lai; Laurence D Parnell; Ingrid B Borecki; Jose M Ordovas
Journal:  Obesity (Silver Spring)       Date:  2008-12-18       Impact factor: 5.002

7.  Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Authors:  Bruce B Duncan; Maria Inês Schmidt; James S Pankow; Heejung Bang; David Couper; Christie M Ballantyne; Ron C Hoogeveen; Gerardo Heiss
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

8.  [Homeostasis model assessment (HOMA) values in Chilean elderly subjects].

Authors:  María Luisa Garmendia; Lydia Lera; Hugo Sánchez; Ricardo Uauy; Cecilia Albala
Journal:  Rev Med Chil       Date:  2010-01-13       Impact factor: 0.553

9.  Adiponectin and protection against type 2 diabetes mellitus.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

10.  Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study.

Authors:  Niina Siitonen; Leena Pulkkinen; Jaana Lindström; Marjukka Kolehmainen; Johan G Eriksson; Mika Venojärvi; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jaakko Tuomilehto; Matti Uusitupa
Journal:  BMC Med Genet       Date:  2011-01-10       Impact factor: 2.103

View more
  3 in total

1.  Leptin level as a biomarker of uncontrolled eating in obesity and overweight.

Authors:  Hassiba Benbaibeche; Abdenour Bounihi; Elhadj Ahmed Koceir
Journal:  Ir J Med Sci       Date:  2020-07-17       Impact factor: 1.568

2.  [Nutrigenetics: potentials and applications in cardiovascular diseases and associated risk factors].

Authors:  Maria Daniela Defagó; Aldo Renato Eynard
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2022-06-06

3.  Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population.

Authors:  Victor Manriquez; Jorge Aviles; Luis Salazar; Nicolas Saavedra; Pamela Seron; Fernando Lanas; Cristina Moreno Fajardo; Mario Hiroyuki Hirata; Rosario Dominguez Crespo Hirata; Alvaro Cerda
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.